Nomograms for preoperative prediction of axillary nodal status in breast cancer

por Dihge, L., Bendahl, P.‐O., Rydén, L.
Publicado 2017

Clinical implications of cardiovascular outcome trials in type 2 diabetes

por Mellbin, L. G., Wang, A., Rydén, L.
Publicado 2019

Systematic screening as a tool for individualized rehabilitation following primary breast cancer treatment: study protocol for the ReScreen randomized controlled trial

por Olsson Möller, U., Rydén, L., Malmström, M.
Publicado 2020

Cosmetic Outcomes and Symmetry Comparison in Patients Undergoing Bilateral Therapeutic Mammoplasty for Breast Cancer

por Gulis, K., Rydén, L., Bendahl, P. O., Svensjö, T.
Publicado 2021

A comprehensive approach to rehabilitation interventions following breast cancer treatment - a systematic review of systematic reviews

por Olsson Möller, U., Beck, I., Rydén, L., Malmström, M.
Publicado 2019

Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients

por Stendahl, M, Kronblad, Å, Rydén, L, Emdin, S, Bengtsson, N O, Landberg, G
Publicado 2004

Validation of the Skåne University Hospital nomogram for the preoperative prediction of a disease-free axilla in patients with breast cancer

por Majid, S, Bendahl, P-O, Huss, L, Manjer, J, Rydén, L, Dihge, L
Publicado 2021

Validated prediction model for positive resection margins in breast-conserving surgery based exclusively on preoperative data

por Ellbrant, J, Gulis, K, Plasgård, E, Svensjö, T, Bendahl, P O, Rydén, L
Publicado 2021

St Gallen 2019 guidelines understage the axilla in lobular breast cancer: a population-based study

por Narbe, U, Bendahl, P-O, Fernö, M, Ingvar, C, Dihge, L, Rydén, L
Publicado 2021

Mannose-Binding Lectin Genotype and Phenotype in Patients With Type 2 Diabetes and Myocardial Infarction: A report from the DIGAMI 2 trial

por Mellbin, L.G., Hamsten, A., Malmberg, K., Steffensen, R., Rydén, L., Öhrvik, J., Hansen, T.K.
Publicado 2010

St Gallen molecular subtypes in screening‐detected and symptomatic breast cancer in a prospective cohort with long‐term follow‐up

por Falck, A. K., Röme, A., Fernö, M., Olsson, H., Chebil, G., Bendahl, P. O., Rydén, L.
Publicado 2016

Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast can...

por Alkner, S., Jensen, M.-B., Rasmussen, B. B., Bendahl, P.-O., Fernö, M., Rydén, L., Mouridsen, H.
Publicado 2017

High frequency of myeloid-derived suppressor cells in sepsis patients, with the granulocytic subtype dominating in Gram-positive cases

por Janols, H, Bergenfelz, C, Allaoui, R, Larsson, A-M, Rydén, L, Björnsson, S, Janciauskiene, S, Wullt, M, Bredberg, A, Leandersson, K
Publicado 2014

Minimizing inequality in access to precision medicine in breast cancer by real‐time population‐based molecular analysis in the SCAN‐B initiative

por Rydén, L., Loman, N., Larsson, C., Hegardt, C., Vallon‐Christersson, J., Malmberg, M., Lindman, H., Ehinger, A., Saal, L. H., Borg, Å.
Publicado 2018

Epidemiology of suicidal feelings in an ageing Swedish population: from old to very old age in the Gothenburg H70 Birth Cohort Studies

por Fässberg, M. M., Vanaelst, B., Jonson, M., Sterner, T. R., Ahlner, F., Wetterberg, H., Rydén, L., Kern, S., Sigström, R., Zettergren, A., Skoog, I., Waern, M.
Publicado 2019